Effect of Different Water Injection Temperatures on the Safety and Comfort of Patients Undergoing Ultrasound Endoscopy of Small Probes Under Intravenous Anesthesia

July 8, 2022 updated by: Li Tian, MD, The Third Xiangya Hospital of Central South University

Small probe endoscopy is currently the best way to diagnose submucosal lesions of the digestive tract. Ultrasonic endoscopy of small probes requires filling the probe and the air in the lumen with water to eliminate gas. Water injection may cause patients with nausea and vomiting, choking cough, abdominal pain, bloating and other uncomfortable symptoms, and in severe cases, it may cause adverse consequences such as breath holding, arrhythmia, and increased blood pressure. At present, some studies have improved patient discomfort by changing the water injection method and developing new acoustic media during the ultrasonic endoscopy of small probes. At present, there are no studies on the impact of different water injection temperatures on the safety and comfort of patients undergoing small probe ultrasound endoscopy under intravenous anesthesia.

In order to improve patient comfort and cooperation, the vast majority of patients currently undergo ultrasound endoscopy under intravenous anesthesia. Under the action of anesthesia and sedative drugs, the patient's thermoregulation center is inhibited, and the change of external temperature is often more obvious to the patient's hemodynamics. Previous studies have found that the temperature of ingested water has an effect on human hemodynamics, digestive tract peristalsis, and visceral body temperature receptors. Injection of relatively low temperature water may reduce the patient's cardiopulmonary load, delay gastrointestinal motility, and shorten the duration of examination; Injecting room or center temperature water may reduce patient coldness and improve patient comfort. Therefore, it is interesting to explore the effects of different water injection temperatures on the safety and comfort of patients with small probe ultrasound endoscopy under intravenous anesthesia, and aim to identify an optimal water injection temperature that can ensure the safety of patient examination and improve patient comfort.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

372

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Hunan
      • Changsha, Hunan, China, 410013
        • Recruiting
        • he Third Xiangya Hospital of Central South University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 73 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

In the Third Xiangya Hospital of Central South University, the First Affiliated Hospital of South China University, the South China Hospital Affiliated to the University of South China, the Hunan Provincial People's Hospital, and the First People's Hospital of Changde City, patients with small probe ultrasound endoscopy under intravenous anesthesia due to gastrointestinal bulge lesions.

Description

Inclusion Criteria:

  • Age ≥ 18 years old, ≤ 75 years old;
  • Gastrointestinal tract raised lesions can be seen in gastrointestinal microscopy;
  • Ultrasonic endoscopy of small probes under intravenous anesthesia is proposed;
  • Clearly understand and voluntarily participate in the study, and sign an informed consent form.

Exclusion Criteria:

  • Exclude patients who do not meet the requirements of conventional small probe ultrasound endoscopy and sedation due to their own conditions: for example, arrhythmias, heart failure, acute myocardial infarction, bronchial asthma during attacks, cervical and thoracic spinal deformities, delirium, mental disorders, duodenal perforations with acute inflammation, etc.;
  • Exclude patients with long-term use of opioids and benzodiazepines;
  • Elimination of pregnant and breastfeeding patients.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Low temperature group
The temperature is 6℃-10℃.
Water injection is a routine procedure for endoscopy of small probe ultrasound, and our intervention is to change the water temperature and observe the effects of different water temperatures on patient safety and comfort.
room temperature group
The temperature is 20℃-24℃.
Water injection is a routine procedure for endoscopy of small probe ultrasound, and our intervention is to change the water temperature and observe the effects of different water temperatures on patient safety and comfort.
Core temperature group
The temperature is 35℃-39℃.
Water injection is a routine procedure for endoscopy of small probe ultrasound, and our intervention is to change the water temperature and observe the effects of different water temperatures on patient safety and comfort.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of cardiopulmonary adverse events
Time Frame: The examination begins until 24 hours after the examination
Respiratory depression, apnea, hypotension, hypertension, tachycardia, bradycardia, etc.
The examination begins until 24 hours after the examination
Patient comfort
Time Frame: The examination begins until 24 hours after the examination
Likert scale The lowest score is 1, and the highest score is 5. A score of 1 is very uncomfortable, and a score of 5 is very uncomfortable. The higher the score, the more comfortable the patient.
The examination begins until 24 hours after the examination

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: L Tian, The Third Xiangya Hospital of Central South University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 14, 2022

Primary Completion (Anticipated)

May 1, 2023

Study Completion (Anticipated)

June 30, 2023

Study Registration Dates

First Submitted

June 12, 2022

First Submitted That Met QC Criteria

July 8, 2022

First Posted (Actual)

July 12, 2022

Study Record Updates

Last Update Posted (Actual)

July 12, 2022

Last Update Submitted That Met QC Criteria

July 8, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • fu3tianli

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

There is not a plan to make IPD available.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Small Probe Ultrasound Endoscopy

Clinical Trials on Change the water injection temperature

3
Subscribe